Sudden cardiac death: epidemiology and risk factors

Related Experiment Video

Updated: Jun 16, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

A Selcuk Adabag1, Russell V Luepker, Véronique L Roger

  • 1Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, MN 55417, USA. adaba001@umn.edu

Nature Reviews. Cardiology
|February 10, 2010
PubMed

Insights

Sudden cardiac death (SCD) remains a significant public health concern. While population-level risk markers have improved, identifying individuals at high risk for SCD and guiding therapy like defibrillators is an ongoing challenge.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Sudden cardiac death (SCD) presents a major public health challenge with diverse causes and evolving trends.
  • Advances in identifying population-level SCD risk markers have been made.
  • Predicting individual high-risk patients for interventions like implantable cardioverter-defibrillators remains difficult.

Purpose of the Study:

  • To review the incidence, trends, and triggers of SCD.
  • To examine demographic, clinical, and genetic risk factors for SCD.
  • To discuss evidence for public-access defibrillators.

Main Methods:

  • Literature review of SCD incidence, trends, triggers, and risk factors.
  • Analysis of demographic, clinical, and genetic data.
  • Evaluation of evidence for public-access defibrillator efficacy.

Main Results:

  • SCD has multiple etiologies and risk factors with changing temporal patterns.
  • Progress exists in population-level risk stratification for SCD.
  • Individualized prediction for interventions like defibrillators is still under development.

Conclusions:

  • Understanding SCD requires ongoing research into its complex risk factors.
  • Further development of predictive tools is needed for targeted interventions.
  • Public-access defibrillators show promise in managing SCD events.

More Related Videos

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...